Latest News

Timber Pharmaceuticals Reports Positive Top-line Results from Phase 2b CONTROL Study Evaluating TMB-001 in Moderate to Severe Congenital Ichthyosis

Timber Pharmaceuticals Reports Positive Top-line Results from Phase 2b CONTROL Study Evaluating TMB-001 in Moderate to Severe Congenital Ichthyosis   ·     Data demonstrate reduction in targeted ...

BioCorRx Files Patent Application with the Russian Patent Office (Rospatent) for Naltrexone Implant

Anaheim, CA – (NewMediaWire) – October 07, 2021 – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment ...

BioElectronics Corporation to Present at the NobleCon Online Pain Management Investor Forum on Channelchek.com

Frederick, MD – (NewMediaWire) – October 07, 2021 – BioElectronics Corporation (OTC: BIEL), a leader in the development and manufacturing of non-invasive electroceuticals, today announced ...

Health system crucial to improve medication adherence for people managing hypertension

Statement Highlights: Hypertension, or high blood pressure, is a major risk factor for stroke, heart disease and kidney disease. Widespread treatment of hypertension can ...